Galectin Therapeutics (GALT) Amortizatization of Intangibles (2019 - 2024)
Galectin Therapeutics' quarterly Amortizatization of Intangibles came in at $10000.0 in Q4 2024, up 11.11% year-on-year from $9000.0 in Q1 2024, and up 11.11% quarter-over-quarter from $9000.0 in Q3 2024.
Galectin Therapeutics has reported Amortizatization of Intangibles for 6 years, with the latest figure at $10000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortizatization of Intangibles rose 11.11% year-over-year to $10000.0; the trailing twelve-month figure through Dec 2024 stood at $37000.0 (up 12.12% YoY), and the FY2025 full-year result was $53000.0, up 43.24% from the prior year.
- Amortizatization of Intangibles for Q4 2024 stood at $10000.0, up from $9000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $32000.0 in Q1 2023, with the low at -$16000.0 in Q2 2023.
- Average Amortizatization of Intangibles over 5 years is $8950.0, with a median of $9000.0 recorded in 2020.
- Peak annual rise in Amortizatization of Intangibles reached 220.0% in 2023, while the deepest fall reached 328.57% in 2023.
- Tracing GALT's Amortizatization of Intangibles over 5 years: stood at $9000.0 in 2020, then increased by 22.22% to $11000.0 in 2021, then dropped by 27.27% to $8000.0 in 2022, then gained by 12.5% to $9000.0 in 2023, then advanced by 11.11% to $10000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $10000.0 (Q4 2024), $9000.0 (Q3 2024), and $9000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Mar 31, 2020 | 9,000.00 |
| Mar 31, 2020 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Mar 31, 2019 | 10,000.00 |